TCTR20170327001CompletedPhase 3
Effectiveness of nebulized 3% hypertonic Saline in hospitalized preschool children with acute wheezing: A prospective, randomized controlled trial
none0 sites50 target enrollmentStarted: March 27, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 6 Weeks to 5 Years (—)
- Sex
- All
Inclusion Criteria
- •Children with acute wheezing
- •Aged 6 weeks to 5 years
- •Admitted to King Chulalongkorn Memorial Hospital
Exclusion Criteria
- •Heart disease
- •Chronic lung disease
- •Current steroid usage
Investigators
Similar Trials
Completed
Phase 2
the effect of Nebulized Hypertonic3% Saline in the Treatment of Acute bronchiolitis in pediatric wardbrochiolitis.Acute bronchiolitis due to respiratory syncytial virusIRCT2012110510222N2Vice Chancellor for Research, Shahrekord Univrsity of Medical Sciences70
Completed
Not Applicable
A comparison of nebulized 3% hypertonic saline and epinephrine versus nebulized normal saline and epinephrine in the treatment of acute bronchiolitisRespiratoryBronchiolitisISRCTN66632312niversity of Alberta, Department of Pediatrics (Canada)46
Recruiting
Phase 2
Effect of hypertonic saline3% in tramadol toxicityAcute tramadol toxicity and side effects.IRCT20220213054017N1Artesh University of Medical Sciences200
Unknown
Phase 1
Hypertonic Saline 3% Nebulizer versus intravenous hypertonic saline 3% in ARDSPACTR201909691980023amr sobhy abdelkway104
Active, not recruiting
Not Applicable
Effectiveness of hipertonic saline serum 3% nebulized in bronchiolitisBronchiolitisEUCTR2010-024230-35-ESFundacion par la investigación biomédica del Hospital Universitario La Paz